Could a stroke drug fix chemo brain? new trial aims to find out
NCT ID NCT07454473
First seen Mar 08, 2026 · Last updated May 23, 2026 · Updated 8 times
Summary
This study tests whether a sublingual tablet containing edaravone and dexborneol can help treat 'chemo brain'—memory and thinking problems caused by chemotherapy. The trial will involve 80 cancer survivors who have received chemotherapy. The goal is to see if the tablet can reduce brain inflammation and oxidative stress, improving cognitive function and quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHEMO-BRAIN are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The First Affiliated Hospital of China Medical University
RECRUITINGShenyang, Liaoning, 110000, China
Conditions
Explore the condition pages connected to this study.